Stereotactic radiotherapy reduces anti-VEGF injection requirements in neovascular age-related macular degeneration
1. Fewer anti-VEGF intravitreal injections were required in the SRT group over 2 years. 2. Change in visual acuity was ...
Tag: Ophthalmology
#VisualAbstract Stereotactic Radiotherapy Reduces Treatment Burden In Neovascular Age-Related Macular Degeneration
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Gene editing improves photoreceptor function in CEP290-associated retinal degeneration
1. In this randomized controlled trial, among patients with centrosomal protein 290 (CEP290)-associated retinal degeneration, subretinal injection of EDIT-101 resulted ...
#VisualAbstract: Low-Dose Daily Aspirin does not Affect the Progression of Age-Related Macular Degeneration
Click here to read this study in JAMA Ophthalmology. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
High dose aflibercept may be promising for treatment of age-related macular degeneration
1. Aflibercept 8 mg was non-inferior to 2 mg for best-corrected visual acuity at 48 weeks. 2. Ocular adverse events ...
High dose aflibercept reduced treatment burden in patients with diabetic macular edema
1. Aflibercept 8 mg was non-inferior to 2 mg for best-corrected visual acuity at 48 weeks. 2. Ocular adverse events ...
Avacincaptad pegol reduces the rate of age-related macular degeneration in geographic atrophy
1. Avacincaptad pegol significantly slowed geographic atrophy over 12 months. 2. Exudative macular neovascularization was comparable among treatment groups. Evidence ...
Risk of hydroxychloroquine retinopathy increases with longer use and higher dosage
1. In this retrospective cohort study, the incidence of hydroxychloroquine retinopathy was 2.5% at 10 years, increasing to 8.6% at ...
Aflibercept monotherapy equivalent to bevacizumab first for diabetic macular edema
1. In patients with diabetic macular edema, aflibercept monotherapy showed no difference in vision improvement compared to step therapy of ...
Faricimab noninferior to aflibercept for treatment of neovascular age-related macular degeneration
1. In both trials, faricimab was demonstrated to be non-inferior to aflibercept at improving visual acuity in neovascular age-related macular ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
